OTSUKA PHARMACEUTICAL CO., LTD.

TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE

#2 | 2026-04-30

US20260115131A1

METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE PREPARATION

#3 | 2026-04-16

US20260102394A1

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

#4 | 2026-01-29

US20260027103A1

PHARMACEUTICAL COMPOSITIONS COMPRISING A QUINOLONE COMPOUND FOR IRRITABLE BOWEL SYNDROME

#5 | 2025-11-27

US20250361224A1

PYRIMIDINE COMPOUND

#6 | 2025-10-23

US20250325541A1

METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS

#7 | 2025-10-16

US20250320453A1

MICROORGANISM BELONGING TO GENUS AKKERMANSIA

#8 | 2025-10-02

US20250304558A1

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY

#9 | 2025-08-07

US20250250243A1

OXAZOLE COMPOUND CRYSTAL

#10 | 2025-07-31

US20250241909A1

INJECTABLE FORMULATION

#11 | 2025-06-12

US20250191730A1

COMPUTER PROGRAM, AND INFORMATION PROCESSING DEVICE AND METHOD

#12 | 2025-06-05

US20250177385A1

COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER

#13 | 2025-05-08

US20250144112A1

SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN

#14 | 2025-05-01

US20250134872A1

ANTITUMOR COMPOSITION

#15 | 2025-04-24

US20250129029A1

ACRIDINE COMPOUND

#16 | 2025-04-24

US20250127813A1

COMBINATION DRUG

#17 | 2025-04-24

US20250127776A1

ORAL PHARMACEUTICAL COMPOSITION

#18 | 2025-04-17

US20250121065A1

INJECTABLE PREPARATION

#19 | 2025-03-27

US20250099459A1

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS ASSOCIATED WITH NEURODEGENERATIVE DISEASE OR IMPULSIVE SYMPTOMS ASSOCIATED WITH MENTAL DISEASE CONTAINING BREXPIPRAZOLE OR SALT THEREOF

#20 | 2025-03-13

US20250082631A1

SLEEP IMPROVING AGENT

#21 | 2025-02-27

US20250064745A1

FREEZE-DRIED ARIPIRAZOLE FORMULATION

#22 | 2025-02-20

US20250057835A1

ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND

#23 | 2025-02-13

US20250051310A1

BENZAZEPINE DERIVATIVES

#24 | 2025-02-13

US20250049749A1

COMPOSITION FOR IMPROVING SLEEP QUALITY OR CONTROLLING AUTONOMIC NERVOUS SYSTEM

#25 | 2025-02-06

US20250042924A1

WATER-SOLUBLE PHYTIN

#26 | 2025-02-06 ✅ Patent 12,370,144 granted on 2025-07-29

US20250041225A1

CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME

#27 | 2025-01-30

US20250031716A1

FROZEN DESSERT COMPOSITION

#28 | 2025-01-02

US20250002481A1

6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR

#29 | 2024-12-19

US20240417376A1

4-(METHYLAMINOPHENOXY)PYRDIN-3-YL-BENZAMIDE DERIVATIVES FOR TREATING CANCER

#30 | 2024-12-19

US20240415774A1

DELAMANID-CONTAINING COMPOSITION

#31 | 2024-12-12

US20240409519A1

HYDROGENATED QUINOXALINES

#32 | 2024-12-05

US20240400520A1

5-METHYL-6-PHENYL-4,5-DIHYDRO-2H-PYRIDAZIN-3-ONE DERIVATIVE

#33 | 2024-11-14

US20240379241A1

INFORMATION PROVISION METHOD FOR PREDICTING HEALTH CONDITION OF CONSUMER AND SUPPORTING HEALTH MAINTENANCE AND IMPROVEMENT

#34 | 2024-11-14

US20240376435A1

KIDNEY ORGANOID AND METHOD FOR PRODUCING SAME

#35 | 2024-11-14

US20240376109A1

PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS

#36 | 2024-11-07 ✅ Patent 12,655,137 granted on 2026-06-16

US20240368136A1

BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS

#37 | 2024-11-07

US20240366573A1

OINTMENT CONTAINING AN OXAZOLE COMPOUND

#38 | 2024-10-03

US20240325348A1

KAEMPFEROL ANALOG-CONTAINING COMPOSITION

#39 | 2024-09-12

US20240299339A1

COMPOSITION FOR SUPPRESSING MUSCLE DAMAGE

#40 | 2024-09-05

US20240293364A1

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

#41 | 2024-08-29

US20240286999A1

AZABICYCLO[3.1.0]HEXANE COMPOUND

#42 | 2024-08-22

US20240277703A1

TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF

#43 | 2024-08-22

US20240277702A1

INJECTABLE FORMULATION

#44 | 2024-07-04

US20240216389A1

DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE

#45 | 2024-07-04 ✅ Patent 12,564,335 granted on 2026-03-03

US20240215867A1

LOW POWER RECEIVER FOR IN VIVO CHANNEL SENSING AND INGESTIBLE SENSOR DETECTION WITH WANDERING FREQUENCY

#46 | 2024-06-27

US20240208999A1

HETEROCYCLIC COMPOUND

#47 | 2024-05-23 ✅ Patent 12,156,941 granted on 2024-12-03

US20240165030A1

Centanafadine pharmaceutical formulations, and methods of making and using same

#48 | 2024-05-16

US20240158380A1

AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM

#49 | 2024-05-16

US20240156811A1

COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER

#50 | 2024-05-09

US20240148699A1

OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION

#51 | 2024-05-02 ✅ Patent 12,528,771 granted on 2026-01-20

US20240140910A1

METHOD FOR PRODUCING CENTANAFADINE

#52 | 2024-04-25

US20240131169A1

CLIPTAC COMPOSITION

#53 | 2024-04-04

US20240109842A1

ACRYLAMIDE COMPOUNDS

#54 | 2024-03-07

US20240076275A1

OXAZOLE COMPOUND CRYSTAL

#55 | 2024-02-08

US20240041774A1

FREEZE-DRIED ARIPIPRAZOLE FORMULATION

#56 | 2023-12-07 ✅ Patent 12,016,927 granted on 2024-06-25

US20230390399A1

Injectable preparation

#57 | 2023-11-30

US20230381194A1

SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN

#58 | 2023-10-26

US20230338337A1

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

#59 | 2023-10-26 ✅ Patent 11,980,690 granted on 2024-05-14

US20230338293A1

Centanafadine pharmaceutical formulations, and methods of making and using same

#60 | 2023-10-26 ✅ Patent 11,957,642 granted on 2024-04-16

US20230338238A1

Internal substance supplier and method of producing molded product

#61 | 2023-10-12

US20230322812A1

CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND

#62 | 2023-10-12

US20230321113A1

PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF

#63 | 2023-10-12

US20230321030A1

KAEMPFEROL AGLYCONE-CONTAINING EXTRACT

#64 | 2023-10-05

US20230313313A1

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

#65 | 2023-09-28

US20230303981A1

BLADDER ORGANOID AND METHOD FOR PRODUCING SAME

#66 | 2023-09-28 ✅ Patent 12,195,496 granted on 2025-01-14

US20230303609A1

2′-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making the same

#67 | 2023-08-31

US20230270142A1

COMPOSITION CONTAINING EQUOL AND ORNITHINE

#68 | 2023-08-24

US20230265073A1

BENZAZEPINE DERIVATIVES

#69 | 2023-08-24 ✅ Patent 11,963,971 granted on 2024-04-23

US20230263818A1

Combination decitabine and cedazuridine solid oral dosage forms

#70 | 2023-07-06

US20230216595A1

Electricity

PHARMA-INFORMATICS SYSTEM

#71 | 2023-06-29

US20230203450A1

METHOD OF PRODUCING ORGANOID DERIVED FROM LUNG EPITHELIAL CELL OR LUNG CANCER CELL

#72 | 2023-06-15 ✅ Patent 12,196,674 granted on 2025-01-14

US20230184676A1

Detection device and detection method

#73 | 2023-05-25

US20230163864A1

Electricity

COMMUNICATION SYSTEM WITH PARTIAL POWER SOURCE

#74 | 2023-05-25

US20230157570A1

IN-BODY POWER SOURCE HAVING HIGH SURFACE AREA ELECTRODE

#75 | 2023-05-18 ✅ Patent 12,306,106 granted on 2025-05-20

US20230152234A1

Detection device

#76 | 2023-05-11

US20230146795A1

ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF SHP2 INHIBITOR PYRIMIDINONE IN COMBINATION WITH NOVEL CANCER MEDICINES IN CANCERS

#77 | 2023-05-04

US20230139808A1

4-(METHYLAMINOPHENOXY)PYRDIN-3-YL-BENZAMIDE DERIVATIVES FOR TREATING CANCER

#78 | 2023-04-06 ✅ Patent 11,759,426 granted on 2023-09-19

US20230104529A1

Centanafadine pharmaceutical formulations, and methods of making and using same

#79 | 2023-03-09 ✅ Patent 11,793,419 granted on 2023-10-24

US20230076111A1

Methods for manufacturing capsules with ingestible event markers

#80 | 2023-03-02

US20230062476A1

GENETICALLY MODIFIED MEGAKARYOCYTE, MODIFIED PLATELET, AND METHODS RESPECTIVELY FOR PRODUCING SAID GENETICALLY MODIFIED MEGAKARYOCYTE AND SAID MODIFIED PLATELET

#81 | 2023-02-16 ✅ Patent 12,458,640 granted on 2025-11-04

US20230049719A1

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

#82 | 2023-02-16

US20230049327A1

DIHYDRATE OF BENZOTHIOPHENE COMPOUND OR OF A SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME

#83 | 2023-02-16 ✅ Patent 11,703,519 granted on 2023-07-18

US20230048882A1

Temperature control system

#84 | 2023-02-02 ✅ Patent 12,643,943 granted on 2026-06-02

US20230036655A1

ANTI-GDF15 ANTIBODY

#85 | 2023-02-02

US20230034761A1

INGESTIBLE DEVICE WITH PHARMACEUTICAL PRODUCT

#86 | 2023-01-26

US20230027710A1